3-46373089-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001394783.1(CCR5):c.187A>T(p.Ser63Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000891 in 1,614,204 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00068 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00091 ( 2 hom. )
Consequence
CCR5
NM_001394783.1 missense
NM_001394783.1 missense
Scores
1
5
13
Clinical Significance
Conservation
PhyloP100: 4.99
Genes affected
CCR5 (HGNC:1606): (C-C motif chemokine receptor 5) This gene encodes a member of the beta chemokine receptor family, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. This protein is expressed by T cells and macrophages, and is known to be an important co-receptor for macrophage-tropic virus, including HIV, to enter host cells. Defective alleles of this gene have been associated with the HIV infection resistance. The ligands of this receptor include monocyte chemoattractant protein 2 (MCP-2), macrophage inflammatory protein 1 alpha (MIP-1 alpha), macrophage inflammatory protein 1 beta (MIP-1 beta) and regulated on activation normal T expressed and secreted protein (RANTES). Expression of this gene was also detected in a promyeloblastic cell line, suggesting that this protein may play a role in granulocyte lineage proliferation and differentiation. This gene is located at the chemokine receptor gene cluster region. An allelic polymorphism in this gene results in both functional and non-functional alleles; the reference genome represents the functional allele. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.03200823).
BS2
High AC in GnomAd4 at 103 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCR5 | NM_001394783.1 | c.187A>T | p.Ser63Cys | missense_variant | 2/2 | ENST00000292303.5 | NP_001381712.1 | |
CCR5AS | NR_125406.1 | n.392-1672T>A | intron_variant, non_coding_transcript_variant | |||||
CCR5 | NM_000579.4 | c.187A>T | p.Ser63Cys | missense_variant | 3/3 | NP_000570.1 | ||
CCR5 | NM_001100168.2 | c.187A>T | p.Ser63Cys | missense_variant | 3/3 | NP_001093638.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCR5 | ENST00000292303.5 | c.187A>T | p.Ser63Cys | missense_variant | 2/2 | 1 | NM_001394783.1 | ENSP00000292303 | P1 | |
CCR5AS | ENST00000701879.1 | n.174-1672T>A | intron_variant, non_coding_transcript_variant | |||||||
CCR5 | ENST00000445772.1 | c.187A>T | p.Ser63Cys | missense_variant | 1/1 | ENSP00000404881 | P1 | |||
CCR5AS | ENST00000451485.2 | n.392-1672T>A | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000677 AC: 103AN: 152208Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
103
AN:
152208
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000835 AC: 210AN: 251378Hom.: 1 AF XY: 0.000839 AC XY: 114AN XY: 135854
GnomAD3 exomes
AF:
AC:
210
AN:
251378
Hom.:
AF XY:
AC XY:
114
AN XY:
135854
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000913 AC: 1335AN: 1461878Hom.: 2 Cov.: 32 AF XY: 0.000895 AC XY: 651AN XY: 727244
GnomAD4 exome
AF:
AC:
1335
AN:
1461878
Hom.:
Cov.:
32
AF XY:
AC XY:
651
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000676 AC: 103AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.000591 AC XY: 44AN XY: 74488
GnomAD4 genome
AF:
AC:
103
AN:
152326
Hom.:
Cov.:
32
AF XY:
AC XY:
44
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
4
ALSPAC
AF:
AC:
6
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
7
ExAC
AF:
AC:
103
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
West Nile virus, susceptibility to;C2675864:Type 1 diabetes mellitus 22 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Nov 09, 2020 | CCR5 NM_000579.3 exon 3 p.Ser63Cys (c.187A>T):This variant has not been reported in the literature but is present in 0.09% (127/129102) of European alleles, including 1 homozygote in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/3-46414580-A-T?dataset=gnomad_r2_1). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Hepatitis C virus, susceptibility to;C1835867:West Nile virus, susceptibility to;C1836230:Susceptibility to HIV infection;C2675864:Type 1 diabetes mellitus 22 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Mar 30, 2021 | CCR5 NM_000579.3 exon 3 p.Ser63Cys (c.187A>T):This variant has not been reported in the literature but is present in 0.09% (127/129102) of European alleles, including 1 homozygote in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/3-46414580-A-T?dataset=gnomad_r2_1). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Uncertain
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M
MutationTaster
Benign
N;N;N
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
B;B
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at